SCHEMBL2665359

SCHEMBL2665359

CCOC(=O)c1c(C(C)C)nc(C(C)C)c(CC(=O)OSO)c1-c1ccccc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 5/20 0.48
ALDH1A1 P00352 4/20 0.38
HPGD P15428 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
HSD17B10 Q99714 1/20 0.38
ALOX5 P09917 3/20 0.37
MAPT P10636 4/20 0.37
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
SLC10A2 Q12908 1/20 0.35
APAF1 O14727 1/20 0.35
MITF O75030 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
TDP2 O95551 1/20 0.35
NSD2 O96028 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2662913 0.85 GCGR (0.65) GCGR
SCHEMBL2662914 0.80 GCGR (0.48) GCGRALDH1A1HPGDNPSR1HSD17B10
SCHEMBL2662916 0.79 GCGR (0.46) GCGRALDH1A1HPGDNPSR1HSD17B10
SCHEMBL2650489 0.74 GCGR (0.44) GCGRALDH1A1HPGDNPSR1HSD17B10
SCHEMBL2650486 0.74 GCGR (0.44) GCGRALDH1A1HPGDNPSR1HSD17B10
SCHEMBL2648932 0.72 GCGR (0.48) GCGRALDH1A1MAPT
SCHEMBL14916763 0.72 LMNA (0.46) GCGRALDH1A1HPGDNPSR1HSD17B10
SCHEMBL2647828 0.71 MAPT (0.46) ALDH1A1HPGDNPSR1HSD17B10MAPT
SCHEMBL8949567 0.70 MAPT (0.69) ALDH1A1HPGDNPSR1HSD17B10MAPT
SCHEMBL28740741 0.70 GCGR (0.48) GCGRALDH1A1ALOX5MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218431-B1 GLUCAGON RECEPTOR ANTAGONISTS FOR THERAPY OF DIABETES AND CONDITIONS ASSOCIATED WITH DIABETES BAYER CORPORATION 2001-04-17 US disclosed
WO-1998004528-A2 SUBSTITUTED PYRIDINES AND BIPHENYLS AS ANTI-HYPERCHOLESTERINEMIC, ANTI-HYPERLIPOPROTEINEMIC AND ANTI-HYPERGLYCEMIC AGENTS BAYER CORPORATION (US) 1998-02-05 WO disclosed